The corporate selected is having status as converted to llp hence financial data is not available. You may check its last filed documents by making a request.
About
Basic Data Updated:
9 days agoIssar Pharmaceuticals Private Limited, a Hyderabad based pharmaceutical company, is known for its groundbreaking research and development in the field of peptide-based healthcare products. These products are then brought to the market for commercialization. The company, IPPL, was founded by Mr. I Ramakrishna Reddy, who has a rich background in the pharmaceutical industry, having previously worked with Shantha Biotechnics Ltd. Currently, IPPL's product portfolio includes a single molecule-Decapeptide, which is being distributed in India by DRL under the brand name Melgain. With a strong focus on innovation, IPPL has an impressive pipeline of products, including a topical treatment for burn wounds that has successfully completed all clinical trials and is now awaiting regulatory approvals f... Read More
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
| CIN/LLPIN/FCRN | U24239TG1995PTC022131 |
| Company No. | 022131 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 31 Oct 1995 |
| Date of AGM | 30 Sep 2022 |
| Date of Balance Sheet | 31 Mar 2022 |
| Listing Status | Unlisted |
| ROC Code | Roc Hyderabad |
Financials of Issar Pharmaceuticals Private Limited
Issar Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 59.01% decrease. The company also saw a substantial fall in profitability, with a 67.96% decrease in profit. The company's net worth Soared by an impressive increase of 13.9%.
Enhance accessibility to Issar Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Issar Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Issar Pharmaceuticals Private Limited
Unlock and access historical data on people associated with Issar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(2)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 16 Jun 2011 | ₹24.20 Cr | Satisfied |
Uti Bank Limited Creation Date: 05 Jun 2006 | ₹1.00 Cr | Satisfied |
The Karnataka Bank Limited Creation Date: 12 Nov 2005 | - | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Issar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Issar Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Issar Investments (India) Private Limited
Active
12 years 10 months Rama Isanaka and Isanaka Shaalini are mutual person
Recent activity within the organization
Annual General Meeting
Issar Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
30 Sep 2022Balance Sheet
Issar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.
31 Mar 2022Charges
A charge registered on 16 Jun 2011 via Charge ID 10294014 with State Bank Of India was fully satisfied on 17 Jun 2016.
17 Jun 2016Director Appointment
Isanaka Shaalini was appointed as a Director was appointed as a Director on 12 Apr 2016 & has been associated with this company since 8 years 20 days .
12 Apr 2016Charges
A charge with State Bank Of India amounted to Rs. 24.20 cr with Charge ID 10294014 was registered on 16 Jun 2011.
16 Jun 2011
Recent News, Updates & Announcement
Cadila acquires skin treatment lotion Melgain from Issar Pharma Mint.Melgain will be marketed in India by Liva Healthcare a specialty division of Zydus group catering to the dermatological segment.
mint 09 Aug 2016
Frequently asked questions
What is the Incorporation or founding date of Issar Pharmaceuticals Private Limited?
